Effects of lipid mediator antagonists on predominant mediator-controlled asthmatic reactions in passively sensitized guinea pigs

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 3, 1999, Pages 1285-1291

  Arakida, Yasuhito ^a   Ohga, Keiko ^a   Suwa, Kiyomi ^a   Yokota, Masaki ^a   Miyata, Keiji ^a   Yamada, Toshimitsu ^a   Honda, Kazuo ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3 [(4 TERT BUTYL 2 THIAZOLYL)METHOXY] 5' [3 (4 CHLOROBENZENESULFONYL)PROPYL] 2' (1H TETRAZOL 5 YLMETHOXY)BENZANILIDE; 3 [(4 TERT BUTYLTHIAZOL 2 YL)METHOXY] 5' [3 (4 CHLOROBENZENESULFONYL) PROPYL] 2' (1H TETRAZOL 5 YLMETHOXY)BENZANILIDE; ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; DALTROBAN; INDOMETACIN; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE D4 RECEPTOR; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PRANLUKAST; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE B2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; GUINEA PIG; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR BLOCKING;

ADMINISTRATION, ORAL; ANIMALS; ASTHMA; CHROMONES; DISEASE MODELS, ANIMAL; GUINEA PIGS; IMMUNIZATION, PASSIVE; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; MALE; MEMBRANE PROTEINS; PHENYLACETATES; RECEPTORS, LEUKOTRIENE; RECEPTORS, THROMBOXANE; SERUM ALBUMIN, BOVINE; SULFONAMIDES; TETRAZOLES; THIAZOLES; THROMBOXANE A2; THROMBOXANE B2;

EID: 0032785363     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Adkins JC and Brogden RN (1998) Zafirlukast: A review of its pharmacology and therapeutic potential in the management of asthma. Drugs 58:121-144.
2. 4-induced smooth muscle contraction in guinea-pig lung parenchyma, but not in trachea. Prostaglandins Leukotrienes Essent Fatty Acids 58:437-440.
3. 2 receptors, in Abstracts of the XVI International Congress of Allergology Clinical Immunology, Suppl 4, p 69.
4. 2 receptors. J Pharmacol Exp Ther 287:633-639.
5. Ashida Y, Matsumoto T, Kuriki H, Shiraishi M, Kato K and Terao S (1989) A novel anti-asthmatic quinone derivative, AA-2414. with potent antagonistic activity against a variety of spasmogenic prostanoids. Prostaglandins 38:91-112.
6. Barnes NC and Pujet JC on behalf of an International Study Group (1997) Pranlukast, a novel leukotriene receptor antagonist: Results of the first European, placebo controlled, multicentre clinical study in asthma. Thorax 52:523-527.
7. Dahlén B, Zetterström O, Björck T and Dahlén SE (1994) The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics. Eur Respir J 7:324-331.
8. Dahlén SE, Hedqvist P, Hammarström S and Samuelsson B (1980) Leukotrienes are potent constrictors of human bronchi. Nature (Lond) 288:484-486.
9. 2-induced bronchoconstriction in the guinea-pig. Br J Pharmacol 104:596-602.
10. 2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthma. J Allergy Clin Immunol 87:23-27.
11. Howell RE, Sickels BD, Woeppel SL, Jenkins LP, Rubin EB and Weichman BM (1994) Leukotrienes mediate antigen-induced airway hyper-reactivity in guinea pigs. J Pharmacol Exp Ther 268:353-358.
12. Jones GL, Saroea HG, Watson RM and O'Byrne PM (1992) Effect of an inhaled thromboxane mimetic (U46619) on airway function in human subjects. Am Rev Respir Dis 145:1270-1274.
13. 2 mimetic) induces airflow obstruction and airway plasma extravasation in the guinea pig: The role of histamine, cyclooxygenase metabolites, leukotrienes and PAF. J Pharmacol Exp Ther 278:268-276.
14. Krell RD, Aharony D, Buckner CK, Keith RA, Kusner EJ, Snyder DW, Bernstein PR, Matassa VG, Yee YK, Brown FJ, Hesp B and Giles RE (1990) The preclinical pharmacology of ICI 204,219: A peptide leukotriene antagonist. Am Rev Respir Dis 141:978-987.
15. 2 synthetase inhibitor (OKY-046) improves abnormal mucociliary transport in asthmatic patients. Ann Allergy 68:53-56.
16. Matsumoto T, Ashida Y and Tsukuda R (1994) Pharmacological modulation of immediate and late airway response and leukocyte infiltration in the guinea pig. J Pharmacol Exp Ther 289:1236-1244.
17. 2 inhibitors in guinea pigs. Biol Pharm Bull 16:1099-1103.
18. 2 receptor antagonist, on U-46619-induced contraction of guinea pig and human tracheal strips in vitro and on bronchoconstriction in guinea pigs in vivo. Prostaglandins 41:375-382.
19. Nakagawa N, Obata T, Kobayashi T, Okada Y, Nambu F, Terawaki T and Aishita H (1992) In vivo pharmacologic profile of ONO-1078: A potent, selective and orally active peptide leukotriene (LT) antagonist. Jpn J Pharmacol 60:217-225.
20. Obata T, Okada Y, Motoishi M, Nakagawa N, Terawaki T and Aishita H (1992) In vitro antagonism of ONO-1078, a newly developed anti-asthmatic agent, against peptide leukotrienes in isolated guinea pig tissues. Jpn J Pharmacol 60:227-237.
21. Ogletree ML and Allen GT (1992) Interspecies differences in thromboxane receptors: Studies with thromboxane receptor antagonists in rat and guinea pig smooth muscle. J Pharmacol Exp Ther 260:789-794.
22. 4 on the microvasculature of guinea-pig skin. Prostaglandins 21:315-321.
23. Rinkema LE, Bemis KG and Fleisch JH (1984) Production and antagonism of cutaneous vascular permeability in the guinea pig in response to histamine, leukotrienes and A23187. J Pharmacol Exp Ther 230:550-557.
24. Sakurai T, Yamaguchi S, Iwama T and Nagai H (1994) Pharmacological studies of platelet-activating factor (PAF)-induced augmentation of response to histamine in guinea-pigs. Prostaglandins Leukotrienes Essent Fatty Acids 51:95-99.
25. Samara E, Cao G, Locke C, Grannerman GR, Dean R and Killian A (1997) Population analysis of the pharmacokinetics and pharmacodynamics of seratrodast in patients with mild to moderate asthma. Clin Pharmacol Ther 62:426-435.
26. Samuelsson B (1983) Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science (Wash DC) 220:568-575.
27. Smith LJ (1991) The role of platelet-activating factor in asthma. An Rev Respir Dis 143:8100-8102.
28. Taniguchi Y, Tamura G, Honma M, Aizawa T, Maruyama N, Shirato K and Takiahima T (1993) The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects. J Allergy Clin Immunol 92:507-512.
29. 4 in guinea pigs. Prostaglandins 23:865-880.
30. 2 and peptidoleukotrienes (Abstract). Pap Am Chem Soc 213: MEDI 075.
31. Wenzel SE (1997) Arachidonic acid metabolites: Mediators of inflammation in asthma. Pharmacotherapy 17:3S-12S.